BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21796628)

  • 1. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
    Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
    Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
    Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
    BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.
    Yin A; Zhang Q; Kong X; Jia L; Yang Z; Meng L; Li L; Wang X; Qiao Y; Lu N; Yang Q; Shen K; Kong B
    Oncotarget; 2015 Dec; 6(42):44373-87. PubMed ID: 26517242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
    de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
    Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
    Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women.
    Boers A; Bosgraaf RP; van Leeuwen RW; Schuuring E; Heideman DA; Massuger LF; Verhoef VM; Bulten J; Melchers WJ; van der Zee AG; Bekkers RL; Wisman GB
    Br J Cancer; 2014 Sep; 111(6):1095-101. PubMed ID: 25032730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
    El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
    Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation for cervical cancer screening: a training set in China.
    Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
    Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
    Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
    Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular progression to cervical precancer, epigenetic switch or sequential model?
    Nedjai B; Reuter C; Ahmad A; Banwait R; Warman R; Carton J; Boer S; Cuzick J; Lorincz AT
    Int J Cancer; 2018 Oct; 143(7):1720-1730. PubMed ID: 29679470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
    J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.